Clemizole hydrochloride
CAS No. 1163-36-6
Clemizole hydrochloride ( AL 20; Allercur )
Catalog No. M10561 CAS No. 1163-36-6
An H1 histamine receptor antagonist that substantially inhibits HCV replication by suppression of NS4B's RNA binding (IC50=24 nM) with little toxicity for the host cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
|
10MG | 58 | In Stock |
|
25MG | 115 | In Stock |
|
50MG | 222 | In Stock |
|
100MG | 354 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameClemizole hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn H1 histamine receptor antagonist that substantially inhibits HCV replication by suppression of NS4B's RNA binding (IC50=24 nM) with little toxicity for the host cells.
-
DescriptionAn H1 histamine receptor antagonist that substantially inhibits HCV replication by suppression of NS4B's RNA binding (IC50=24 nM) with little toxicity for the host cells; also selectively and efficiently blocks TRPC5 currents and Ca(2+) entry with IC50 of 1-1.3 uM, 6-fold selectivity over TRPC4β (IC50 = 6.4 μM), and almost 10-fold selectivity over TRPC3 (IC50 =9.1 uM) and TRPC6 (IC50=11.3 uM), only very weakly affects TRPM3, TRPM8 and TRPV1, V2, V3, and V4 channels. HCV Infection Phase 2 Clinical
-
SynonymsAL 20; Allercur
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorNS4BH1histaminereceptor
-
Research AreaInfection
-
IndicationHCV Infection
Chemical Information
-
CAS Number1163-36-6
-
Formula Weight362.30
-
Molecular FormulaC19H21Cl2N3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 3.6 mg/mL
-
SMILESCl.ClC1=CC=C(CN2C(CN3CCCC3)=NC3=CC=CC=C23)C=C1
-
Chemical Name1H-Benzimidazole, 1-[(4-chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-, hydrochloride (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Richter JM, et al. Mol Pharmacol. 2014 Nov;86(5):514-21.
2. Einav S, et al. Nat Biotechnol. 2008 Sep;26(9):1019-27.
3. Einav S, et al. J Infect Dis. 2010 Jul 1;202(1):65-74.
2. Einav S, et al. Nat Biotechnol. 2008 Sep;26(9):1019-27.
3. Einav S, et al. J Infect Dis. 2010 Jul 1;202(1):65-74.
molnova catalog
related products
-
RQ00203078
RQ-00203078 is a highly selective, potent and orally available TRPM8 antagonist (IC50 values are 5.3 and 8.3 nM for rat and human channels respectively).
-
MDR-652
MDR-652 is a highly specific and efficacious agonist of nonpungent transient receptor potential vanilloid 1 (TRPV1) with Ki value of 11.4 nM and 23.8 nM for hTRPV1 and rTRPV1 respectively and EC50s for hTRPV1 and rTRPV1 are 5.05 and 93 nM respectively.
-
GFB-8438
GFB-8438 is a potent and subtype selective inhibitor of TRPC5(IC50s of 0.18 and 0.29 μM of hTRPC5 and hTRPC4, respectively).